All Stories

Dexcom receives FDA warning letter over CGM manufacturing issues

Dexcom has received a warning letter from the FDA, following two inspections of the diabetes tech company's facilities last year.

Mar 10, 2025 - 17:02
 0
Dexcom receives FDA warning letter over CGM manufacturing issues
Dexcom has received a warning letter from the FDA, following two inspections of the diabetes tech company's facilities last year.
Read More

Tags:

Previous Article

Convince Your Boss Why You Should Attend EventCamp 2025 & By Heather Apse

Next Article

Arrowhead finds RNAi kidney disease candidate is well tolerated in phase 1/2 IgA...

Related Posts

VC firm Kineticos launches biotech to develop fresh approach to antibiotic resistance

VC firm Kineticos launches biotech to develop fresh app...

Feb 24, 2025  0

Amgen enters Maritime, launching 2 late-stage obesity trials for MariTide

Amgen enters Maritime, launching 2 late-stage obesity t...

Mar 5, 2025  0

Blackstone buys majority stake in CMIC, Japan's largest contract research organization

Blackstone buys majority stake in CMIC, Japan's largest...

Mar 4, 2025  0